SYNTONIX PHARMACEUTICALS INC has a total of 72 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are FOUNTAIN BIOPHARMA INC, MEDIMMUNE INC and CREATIVE PEPTIDES SWEDEN AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 6 | |
#4 | China | 6 | |
#5 | EPO (European Patent Office) | 6 | |
#6 | Israel | 5 | |
#7 | Australia | 4 | |
#8 | Brazil | 4 | |
#9 | Taiwan | 4 | |
#10 | Norway | 3 | |
#11 | Japan | 2 | |
#12 | Republic of Korea | 2 | |
#13 | Mexico | 2 | |
#14 | South Africa | 2 | |
#15 | EAPO (Eurasian Patent Organization) | 1 | |
#16 | Hong Kong | 1 | |
#17 | Iceland | 1 | |
#18 | Luxembourg | 1 | |
#19 | Montenegro | 1 | |
#20 | Serbia | 1 | |
#21 | Turkey | 1 | |
#22 | Ukraine | 1 | |
#23 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Mezo Adam R | 41 |
#2 | Peters Robert T | 31 |
#3 | Bitonti Alan J | 26 |
#4 | Mcdonnell Kevin A | 21 |
#5 | Low Susan C | 18 |
#6 | Rivera Daniel S | 18 |
#7 | Stattel James M | 11 |
#8 | Hehir Cristina Tan A | 9 |
#9 | Castro Alfredo | 9 |
#10 | Stattel James | 3 |
Publication | Filing date | Title |
---|---|---|
US2010048488A1 | Immunomodulatory peptides | |
TW200911289A | Immunomodulatory peptides | |
TW200815599A | Pc5 as a factor ix propeptide processing enzyme | |
CN101421297A | Peptides that block the binding of igg to fcrn | |
TW200745163A | Peptides that block the binding of IgG to FcRn | |
AU2005207960A1 | Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility | |
US2005260194A1 | Immunoglobulin chimeric monomer-dimer hybrids | |
CA2522690A1 | Inhibition of drug binding to serum albumin | |
TW200510457A | Immunoglobulin chimeric monomer-dimer hybrids |